| {"0": "Electron transport chain oxphos system in mitochondria", "1": "Nonalcoholic fatty liver disease", "2": "Mitochondrial complex iv assembly", "3": "Ferroptosis", "4": "Mitochondrial complex i assembly model oxphos system", "5": "Sphingolipid metabolism overview", "6": "Cholesterol metabolism with bloch and kandutschrussell pathways", "7": "Sphingolipid metabolism integrated pathway", "8": "Sphingolipid pathway", "9": "Sphingolipid metabolism in senescence", "10": "Oxidative phosphorylation", "11": "Glycerophospholipid biosynthetic pathway", "12": "Cholesterol biosynthesis pathway", "13": "Glycosylation and related congenital defects", "14": "Mitochondrial immune response to sarscov2", "15": "Intracellular trafficking proteins involved in cmt neuropathy", "16": "Metapathway biotransformation phase i and ii", "17": "Allograft rejection", "18": "Alzheimers disease and mirna effects", "19": "Degradation pathway of sphingolipids including diseases", "20": "Mitochondrial long chain fatty acid betaoxidation", "21": "Alzheimers disease", "22": "Fatty acid betaoxidation", "23": "Novel intracellular components of rigilike receptor rlr pathway", "24": "Small cell lung cancer", "25": "Apoptosis modulation and signaling", "26": "Ppar signaling pathway", "27": "Nucleotidebinding oligomerization domain nod pathway"} |